Huntington National Bank Has $192,000 Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Huntington National Bank boosted its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 7.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 809 shares of the medical research company’s stock after buying an additional 56 shares during the quarter. Huntington National Bank’s holdings in IQVIA were worth $192,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Oppenheimer Asset Management Inc. raised its position in shares of IQVIA by 17.3% in the third quarter. Oppenheimer Asset Management Inc. now owns 13,360 shares of the medical research company’s stock valued at $3,166,000 after purchasing an additional 1,974 shares during the period. Cumberland Partners Ltd raised its holdings in IQVIA by 4.1% in the 3rd quarter. Cumberland Partners Ltd now owns 1,660 shares of the medical research company’s stock valued at $393,000 after acquiring an additional 65 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its position in IQVIA by 3.9% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,023,264 shares of the medical research company’s stock worth $242,483,000 after acquiring an additional 38,307 shares during the last quarter. GSA Capital Partners LLP bought a new stake in shares of IQVIA during the third quarter worth approximately $230,000. Finally, Apollon Wealth Management LLC grew its position in shares of IQVIA by 9.6% in the third quarter. Apollon Wealth Management LLC now owns 4,874 shares of the medical research company’s stock valued at $1,155,000 after purchasing an additional 427 shares during the last quarter. Institutional investors own 89.62% of the company’s stock.

Analysts Set New Price Targets

IQV has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft reduced their price target on IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a research note on Friday, November 1st. JPMorgan Chase & Co. lowered their price target on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. Jefferies Financial Group downgraded shares of IQVIA from a “buy” rating to a “hold” rating and cut their price objective for the company from $266.00 to $242.00 in a report on Wednesday, July 24th. Argus raised shares of IQVIA to a “strong-buy” rating in a report on Wednesday, July 31st. Finally, Evercore ISI cut their price target on IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $259.13.

IQVIA Stock Down 5.1 %

IQV stock opened at $192.68 on Monday. The firm has a 50-day moving average price of $226.95 and a 200-day moving average price of $228.24. IQVIA Holdings Inc. has a 12 month low of $189.63 and a 12 month high of $261.73. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock has a market capitalization of $34.97 billion, a P/E ratio of 25.29, a price-to-earnings-growth ratio of 1.98 and a beta of 1.51.

Insider Buying and Selling

In related news, insider Eric Sherbet sold 1,300 shares of the business’s stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the sale, the insider now owns 19,536 shares in the company, valued at $4,812,302.88. The trade was a 6.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.60% of the stock is owned by corporate insiders.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.